ATEM Capital
Overview
ATEM Capital manages evergreen Life Sciences investment fund - Health Square Fund (HSF). HSF acts as a consolidator of capital flows from the Emerging Markets and invests into the biotech innovation hubs of the US/Western Europe.\\HSF's international team combines big-picture business perspective with decades of investment, scientific, legal, portfolio risk management and operational experience. The fund is audited by a Big-4 firm.\\Our Advisory Board comprises high-caliber entrepreneurs, VC veterans and seasoned Wall Street professionals.
Investment Focus
- Innovative technologies in healthcare and life sciences
- Strong management teams
- Scalable business models
- Potential for significant market impact
Portfolio Companies
Reach ATEM Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about ATEM Capital
What sectors does ATEM Capital invest in?
ATEM Capital invests in Healthcare, Digital Health, Medtech and Biotechnology, and is based in New York, New York, United States. ATEM Capital is listed as a venture capital in the ConnectSafely investor database.
What stage does ATEM Capital invest at?
ATEM Capital backs companies at Early Stage and Late Stage.
Which regions does ATEM Capital invest in?
ATEM Capital invests across United States and Europe.
Who are the partners at ATEM Capital?
Team members listed for ATEM Capital include Ilya Yasny (Managing Partner) and Elena Maley (Managing Partner).
What companies has ATEM Capital invested in?
ATEM Capital's portfolio includes Triumvira Immunologics, Arpeggio Bio and Iridia.
How do I contact ATEM Capital?
ATEM Capital's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
